Arthritis, Rheumatoid
367
16
24
252
Key Insights
Highlights
Success Rate
88% trial completion (above average)
Published Results
116 trials with published results (32%)
Research Maturity
252 completed trials (69% of total)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 17/100
9.0%
33 terminated out of 367 trials
88.4%
+1.9% vs benchmark
25%
93 trials in Phase 3/4
46%
116 of 252 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 252 completed trials
Clinical Trials (367)
Application of the Personalized N-of-1 Trial Design in Patients With Rheumatoid Arthritis
A Study of BMS-986528 in Participants With Refractory Rheumatoid Arthritis
Methotrexate and Metformin in Rheumatoid Arthritis Patients
A Study of Jyseleca Tablet (Filgotinib Maleate) in Korean Participants
Multidisciplinary Approach for Treat To Target In Rheumatoid Arthritis
Characterization of Breg Cells
R-2487 in Patients With Rheumatoid Arthritis
A Clinical Study of Tulisokibart (MK-7240) to Treat Rheumatoid Arthritis (RA) (MK-7240-014)
Study of Gynecological Follow-up of Patients With Autoimmune Disease or Inflammatory Rheumatism
Chronic Pain in Rheumatoid Arthritis
Defining Stress REsilience And Mindfulness Effects in Rheumatoid Arthritis
BIOTIPRA: BIOmarker-guided Treatment Decisions In Psoriatic and Rheumatoid Arthritis
Bone Erosions in Rheumatoid Arthritis - Characterization Evaluated by Imaging and Histology
Fucoidan in the Treatment of Active Rheumatoid Arthritis
Anatomical Shoulder Domelock System Study
INFINITY™ With ADAPTIS™ Technology Study
Evaluation of Medium Cross-linked Polyethylene With and Without Vitamin E for Total Knee Arthroplasty
Laser-based Photoacoustic Tomography of Human Inflammatory Arthritis
UK Infinity, Post-Market Clinical Follow-up Study
Effects of Phytocannabinoids on Immune Response and Autophagy During Chronic Immune-mediated Inflammatory Diseases